![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evolution of the HCV Viral Population from
the One Patient with S282T Detected at Relapse after Sofosbuvir Monotherapy
|
|
|
Reported by Jules Levin
(IDRW) International Workshop on HIV & Hepatitis
Virus Drug Resistance and Curative Strategies
June 4-8, 2013
Toronto, Canada
Charlotte Hedskog, Viktoria Gontcharova, Bin Han, Ross Martin, Michael D. Miller, Hongmei Mo, Evguenia S. Svarovskaia
Gilead Sciences Inc, Foster City, CA, United States
![Res1.gif](../images/060913/060913-9/Res1.gif)
![Res2.gif](../images/060913/060913-9/Res2.gif)
![Res3.gif](../images/060913/060913-9/Res3.gif)
![Res4.gif](../images/060913/060913-9/Res4.gif)
![Res5.gif](../images/060913/060913-9/Res5.gif)
![Res6.gif](../images/060913/060913-9/Res6.gif)
![Res7.gif](../images/060913/060913-9/Res7.gif)
![Res8.gif](../images/060913/060913-9/Res8.gif)
![Res9.gif](../images/060913/060913-9/Res9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|